HLA-B27 spondyloarthritis and spotted fever rickettsiosis: case-based review

Rheumatol Int. 2019 Sep;39(9):1643-1650. doi: 10.1007/s00296-019-04330-8. Epub 2019 May 27.

Abstract

Rickettsia rickettsii, a tick borne disease, is the pathogen responsible for inducing Rocky Mountain Spotted Fever (RMSF), an illness that can progress to fulminant multiorgan failure and death. We present a case where R. rickettsii, acquired on a camping trip, precipitated a flare of peripheral arthritis and episcleritis in an HLA-B27 positive patient. Although Yersinia, Salmonella, Mycobacteria, Chlamydia, Shigella, Campylobacter, and Brucella have been previously associated with HLA-B27 spondyloarthritis, this unusual case demonstrates that obligate intracellular rickettsial organisms, and specifically, R. rickettsii, can also induce flares of HLA-B27 spondyloarthritis. Rickettsial infections in general can rapidly become fatal in both healthy and immunosuppressed patients, and thus, prompt diagnosis and therapy are required.

Keywords: HLA-B27; Infectious; Reactive arthritis; Rickettsia; Spondyloarthritis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Certolizumab Pegol / administration & dosage*
  • Disease Progression
  • Doxycycline / administration & dosage
  • Female
  • HLA-B27 Antigen / genetics
  • HLA-B27 Antigen / immunology*
  • Humans
  • Immunocompromised Host*
  • Middle Aged
  • Rickettsia rickettsii / drug effects
  • Rickettsia rickettsii / immunology*
  • Spondylarthritis / diagnosis
  • Spondylarthritis / drug therapy*
  • Spondylarthritis / genetics
  • Spondylarthritis / immunology
  • Spotted Fever Group Rickettsiosis / diagnosis
  • Spotted Fever Group Rickettsiosis / drug therapy
  • Spotted Fever Group Rickettsiosis / immunology
  • Spotted Fever Group Rickettsiosis / microbiology*
  • Treatment Outcome
  • Tumor Necrosis Factor Inhibitors / administration & dosage*

Substances

  • Anti-Bacterial Agents
  • HLA-B27 Antigen
  • Tumor Necrosis Factor Inhibitors
  • Doxycycline
  • Certolizumab Pegol